Matthew G. Lloyd

Matthew G. Lloyd

Auto-generated profile, based on publicly available information

Matthew G. Lloyd

Process and Analytical Chemistry, Pharmaron UK Ltd., West Hill Innovation Park, Hertford Road, Hoddesdon EN11 9FH, U.K.

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2020 in Journal of Medicinal Chemistry
Verified
Journal Article
Open access
BBBenjamin R. Bellenie
Benjamin R. Bellenie
KCKwai-Ming J. Cheung
Kwai-Ming J. Cheung
AVAna Varela
Ana Varela
OPOlivier A. Pierrat
Olivier A. Pierrat
GCGavin W. Collie
Gavin W. Collie
SHSwen Hoelder
Swen Hoelder
Deregulation of the transcriptional repressor BCL6 enables tumorigenesis of germinal center B-cells, and hence BCL6 has been proposed as a therapeutic target for the treatment of diffuse large B-cell lymphoma (DLBCL). Herein we report the discovery of a series of benzimidazolone inhibitors of the protein–protein interaction between BCL6 and its co-repressors. A subset of these inhibitors were found to cause rapid degradation of BCL6, and optimization of pharmacokinetic properties led to the discovery of 5-((5-chloro-2-((3R,5S)-4,4-difluoro-3,5-dimethylpiperidin-1-yl)pyrimidin-4-yl)amino)-3-(3-hydroxy-3-methylbutyl)-1-methyl-1,3-dihydro-2H-benzo[d]imidazol-2-one (CCT369260), which reduces BCL6 levels in a lymphoma xenograft mouse model following oral dosing.

3 June 2022 in Journal of Medicinal Chemistry
Verified
Journal Article
Open access
ODOwen A. Davis
Owen A. Davis
KCKwai-Ming J. Cheung
Kwai-Ming J. Cheung
ABAlfie Brennan
Alfie Brennan
MLMatthew G. Lloyd
Matthew G. Lloyd
MRMatthew J. Rodrigues
Matthew J. Rodrigues
SHSwen Hoelder
Swen Hoelder
To identify new chemical series with enhanced binding affinity to the BTB domain of B-cell lymphoma 6 protein, we targeted a subpocket adjacent to Val18. With no opportunities for strong polar interactions, we focused on attaining close shape complementarity by ring fusion onto our quinolinone lead series. Following exploration of different sized rings, we identified a conformationally restricted core which optimally filled the available space, leading to potent BCL6 inhibitors. Through X-ray structure-guided design, combined with efficient synthetic chemistry to make the resulting novel core structures, a >300-fold improvement in activity was obtained by the addition of seven heavy atoms.

1 September 2015 in Tetrahedron
Verified
Journal Article
Closed access
MLMatthew G. Lloyd
Matthew G. Lloyd
MDMariantonietta D'ACunto
Mariantonietta D'ACunto
RTRichard J.K. Taylor
Richard J.K. Taylor
WUWilliam P. Unsworth
William P. Unsworth

2 May 2014 in Organic Letters
Verified
Journal Article
Closed access
MLMatthew G. Lloyd
Matthew G. Lloyd
RTRichard J. K. Taylor
Richard J. K. Taylor
WUWilliam P. Unsworth
William P. Unsworth

17 December 2015 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
MLMatthew G. Lloyd
Matthew G. Lloyd
MDMariantonietta D'Acunto
Mariantonietta D'Acunto
RTRichard J. K. Taylor
Richard J. K. Taylor
WUWilliam P. Unsworth
William P. Unsworth
A regio- and stereoselective one-pot C–H insertion/olefination protocol has been developed for the late stage installation of α-methylene-γ-butyrolactones into conformationally restricted cyclohexanol-derivatives.

23 August 2016 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
MLMatthew G. Lloyd
Matthew G. Lloyd
RTRichard J. K. Taylor
Richard J. K. Taylor
WUWilliam P. Unsworth
William P. Unsworth
Phosphorylated cyclopropanes, generated via the Rh(II)-catalysed intramolecular cyclopropanation of α-(diethoxyphosphoryl)acetates, have been found to be useful precursors in the synthesis of α-alkylidene-γ-butyrolactones. These cyclopropyl intermediates undergo regioselective reductive ring-opening and subsequent Horner–Wadsworth–Emmons olefination to complete the synthesis. Total syntheses of (±)-savinin and (±)-gadain, as well as the first total synthesis of (±)-peperomin E, are all described using this method.